These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 364602)

  • 1. The selection of patients for controlled trials.
    Bywaters EG
    Rheumatol Rehabil; 1978; Suppl():124-5. PubMed ID: 364602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical evaluation of new drugs].
    Lewis PJ
    Rev Prat; 1982 Sep; 32(41-42):2649-50 passim. PubMed ID: 7146802
    [No Abstract]   [Full Text] [Related]  

  • 3. [Principles of controlled trials (author's transl)].
    Fink H
    Arzneimittelforschung; 1978; 28(11a):2017-9. PubMed ID: 383091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A risky business: the detection of adverse drug reactions in clinical trials and post-marketing exercises.
    Corrigan OP
    Soc Sci Med; 2002 Aug; 55(3):497-507. PubMed ID: 12144155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ethics of randomization].
    Arpaillange P; Dion S
    Biomed Pharmacother; 1984; 38(9-10):426-9. PubMed ID: 6529599
    [No Abstract]   [Full Text] [Related]  

  • 6. The principles of controlled clinical trials of drugs.
    Herman ZS
    Int J Clin Pharmacol Biopharm; 1978 Aug; 16(8):361-4. PubMed ID: 357309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Controlled clinical therapy study. Position papers on the contribution by S. Koller: Attack against progress in medicine--contention of illegality of controlled clinical therapy studies in Fortschr, Med. 95, 42:2570 (1977). Misleading the public].
    Fiebig U
    Fortschr Med; 1978 Dec; 96(47-48):2377-8. PubMed ID: 363579
    [No Abstract]   [Full Text] [Related]  

  • 8. Controversy I: Patients or healthy volunteers for pharmacokinetic studies?
    Brazzell RK; Colburn WA
    J Clin Pharmacol; 1986 Apr; 26(4):242-7. PubMed ID: 3700681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic trials in pregnant women].
    Pontonnier G; Grandjean H
    Ann Anesthesiol Fr; 1975; 16 Spec No 1():20-4. PubMed ID: 2079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection bias and treatment heterogeneity in clinical trials.
    Longford NT
    Stat Med; 1999 Jun; 18(12):1467-74. PubMed ID: 10398285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The placebo dilemma.
    Schindel L
    Eur J Clin Pharmacol; 1978 May; 13(3):231-5. PubMed ID: 668779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of healthy volunteers for phase I studies.
    Sibille M
    Fundam Clin Pharmacol; 1990; 4 Suppl 2():167s-176s. PubMed ID: 2093628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The conduct of phase I-II clinical trials in children with cancer.
    Pratt CB
    Med Pediatr Oncol; 1991; 19(4):304-9. PubMed ID: 2056975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled clinical trials and medical ethics.
    Burkhardt R; Kienle G
    Lancet; 1978 Dec 23-30; 2(8104-5):1356-9. PubMed ID: 82854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled clinical trials and medical ethics.
    Howard J; Friedman L
    Lancet; 1979 Feb; 1(8112):385. PubMed ID: 85035
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical drug testing in the United States].
    Engelbart S
    Fortschr Med; 1983 Jun; 101(22):1021-2, 1049. PubMed ID: 6347848
    [No Abstract]   [Full Text] [Related]  

  • 18. The last patient in a drug trial.
    Hastings Cent Rep; 1981 Dec; 11(6):21-3. PubMed ID: 7333839
    [No Abstract]   [Full Text] [Related]  

  • 19. A design for phase II testing of anticancer agents within a phase III clinical trial.
    Schaid DJ; Ingle JN; Wieand S; Ahmann DL
    Control Clin Trials; 1988 Jun; 9(2):107-18. PubMed ID: 3396362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the presence of an open-label antidepressant treatment period influence study outcome in clinical trials examining augmentation/combination strategies in treatment partial responders/nonresponders with major depressive disorder?
    Iovieno N; Papakostas GI
    J Clin Psychiatry; 2012 May; 73(5):676-83. PubMed ID: 22569112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.